EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

30-Day Complications After Day-Case Versus Inpatient Ureterorenoscopy: A Retrospective Cohort Study

Roos Van Slagmaat, Esther Pita Marieke Duindam, Jessica Steenbruggen, Diederick Duijvesz iD

Journal of Clinical Medicine · 29.04.2026 · 15 (9) · 3391

DOI: 10.3390/jcm15093391 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.04.2026. Verfasst von Roos Van Slagmaat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Canisius Wilhelmina Hospital Nijmegen, 6532 SZ Nijmegen, The Netherlands. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rising healthcare demands and the impact of the COVID-19 pandemic have prompted a transition from inpatient to day-case ureterorenoscopy (URS) to reduce costs and optimise bed capacity. Although international studies support the safety of day-case URS, evidence from The Netherlands is limited. Furthermore, Dutch and European urological guidelines do not provide explicit recommendations for standardising URS as a day-case procedure. The present study compares 30-day complication rates of URS between the pre-COVID-19 era (2019) and current practice (2023).

Methods

A retrospective cohort study was conducted, including all patients who underwent elective URS at Canisius Wilhelmina Hospital, the Netherlands, in 2019 and 2023. Patients under 18 years of age, as well as those undergoing emergency procedures and combined procedures, were excluded. The primary outcome was the occurrence of complications within 30 days, classified according to the Clavien–Dindo system. Secondary outcomes included identification of clinical and procedural predictors of complications. Statistical analysis was performed using SPSS and included Chi-square tests, t-tests, Mann–Whitney U tests, and multivariable logistic regression.

Results

Of 619 screened patients, 495 were included: 230 patients in 2019, 265 patients in 2023. Baseline characteristics were comparable between groups. The overall complication rate was low (15.7% in 2019, 20.0% in 2023) and did not differ significantly between day-case and inpatient URS (p = 0.209). In multivariable logistic regression, day-case URS was not associated with an increased risk of complications (OR = 0.91, 95% CI 0.46–1.81, p = 0.795). There were no other significant predictors of complications.

Conclusions

The findings suggest that day-case ureterorenoscopy may be a safe and feasible approach and may offer opportunities for cost savings, as no increase in postoperative complications was observed compared with inpatient procedures. However, these results should be interpreted with caution given the observational design.

Schlagwörter

Stichwörter der Autor:innen

complicationsday-careureterorenoscopyurolithiasis

Autor:innen und Institutionen

  • Department of Urology, Canisius Wilhelmina Hospital Nijmegen, 6532 SZ Nijmegen, The Netherlands.

ORCID-Profile: Diederick Duijvesz

Zitieren

APA

Van Slagmaat, R., Duindam, E. P. M., Steenbruggen, J., & Duijvesz, D. (2026). 30-Day Complications After Day-Case Versus Inpatient Ureterorenoscopy: A Retrospective Cohort Study. Journal of Clinical Medicine, 15(9), 3391. https://doi.org/10.3390/jcm15093391

Vancouver

Van Slagmaat R, Duindam EPM, Steenbruggen J, Duijvesz D. 30-Day Complications After Day-Case Versus Inpatient Ureterorenoscopy: A Retrospective Cohort Study. Journal of Clinical Medicine. 2026;15(9):3391. doi:10.3390/jcm15093391

BibTeX
@article{VanSlagmaat2026,
  author = {Van Slagmaat, Roos and Duindam, Esther Pita Marieke and Steenbruggen, Jessica and Duijvesz, Diederick},
  title = {30-Day Complications After Day-Case Versus Inpatient Ureterorenoscopy: A Retrospective Cohort Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {9},
  pages = {3391},
  doi = {10.3390/jcm15093391}
}
Kostenlos starten →